Müller CE (2009). „Prodrug approaches for enhancing the bioavailability of drugs with low solubility”. Chemistry & Biodiversity. 6 (11): 2071—83. PMID19937841. doi:10.1002/cbdv.200900114.
Coller JK, Christrup LL, Somogyi AA (2009). „Role of active metabolites in the use of opioids”. European Journal of Clinical Pharmacology. 65 (2): 121—39. PMID18958460. doi:10.1007/s00228-008-0570-y.
Müller CE (2009). „Prodrug approaches for enhancing the bioavailability of drugs with low solubility”. Chemistry & Biodiversity. 6 (11): 2071—83. PMID19937841. doi:10.1002/cbdv.200900114.
Haffen E, Paintaud G, Berard M, Masuyer C, Bechtel Y, Bechtel PR (2000). „On the assessment of drug metabolism by assays of codeine and its main metabolites”. Therapeutic Drug Monitoring. 22 (3): 258—65. PMID10850391.
Raffa RB (1996). „A novel approach to the pharmacology of analgesics”. The American Journal of Medicine. 101 (1A): 40S—46S. PMID8764759.
Zhou SF, Zhou ZW, Yang LP, Cai JP (2009). „Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development”. Current Medicinal Chemistry. 16 (27): 3480—675. PMID19515014.
Coller JK, Christrup LL, Somogyi AA (2009). „Role of active metabolites in the use of opioids”. European Journal of Clinical Pharmacology. 65 (2): 121—39. PMID18958460. doi:10.1007/s00228-008-0570-y.